Cargando…

Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation

INTRODUCTION: Glycemic control in type 2 diabetic patients is a constant challenge. The objective of our study is to evaluate glycemic control in type 2 diabetic patients since the start of the "Covid-19" pandemic by comparing their glycemic and degenerative profiles in the pre-confinement...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmehraoui, O., Berrabeh, S., Messaoudi, N., Derkaoui, N., Zerrouki, D., Rouf, S., Latrech, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050607/
https://www.ncbi.nlm.nih.gov/pubmed/35505685
http://dx.doi.org/10.1016/j.amsu.2022.103689
_version_ 1784696404139048960
author Elmehraoui, O.
Berrabeh, S.
Messaoudi, N.
Derkaoui, N.
Zerrouki, D.
Rouf, S.
Latrech, H.
author_facet Elmehraoui, O.
Berrabeh, S.
Messaoudi, N.
Derkaoui, N.
Zerrouki, D.
Rouf, S.
Latrech, H.
author_sort Elmehraoui, O.
collection PubMed
description INTRODUCTION: Glycemic control in type 2 diabetic patients is a constant challenge. The objective of our study is to evaluate glycemic control in type 2 diabetic patients since the start of the "Covid-19" pandemic by comparing their glycemic and degenerative profiles in the pre-confinement,per and post-confinement periods. PATIENTS AND METHODS: This is a descriptive and analytical,cross-sectional study,bringing together 720 type 2 diabetic patients followed by teleconsultation at the endocrinology,diabetology and nutrition department,from mid-March to mid-October 2020. RESULTS: The mean age of the patients was 62.5 ± 11.3 years, with a sex ratio (M / F) of 0.71,the average duration of diabetes was 10.6 ± 7, 4 years.The mean pre-lockdown Hba1c level was 8.5±1.9%.Only 137 patients have been able to do the HBa1c test since the start of lockdown,which averaged 8.4 ± 1.8%.Regarding the degenerative complications installed after containment,4.4% of the patients presented an acute coronary syndrome,2.2% a cerebrovascular accident,1.4% developed a stage 2 chronic renal disease,and a foot injury appeared in 5.1% of patients while no patient developed diabetic retinopathy among those who performed ophthalmic evaluation.In our series,the death rate was estimated at 1.8%.Drug therapy was adjusted in the majority of patients with initiation of insulin therapy in 7.2% of patients and intensification of insulin doses in 9.4% of patients. CONCLUSION: At the heart of the pandemic Covid-19 crisis,teleconsultation has taken an essential place in the strategy of access to care, particularly the monitoring of chronic diseases,the results of our study are similar to those of other studies published during this pandemic.
format Online
Article
Text
id pubmed-9050607
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90506072022-04-29 Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation Elmehraoui, O. Berrabeh, S. Messaoudi, N. Derkaoui, N. Zerrouki, D. Rouf, S. Latrech, H. Ann Med Surg (Lond) Cohort Study INTRODUCTION: Glycemic control in type 2 diabetic patients is a constant challenge. The objective of our study is to evaluate glycemic control in type 2 diabetic patients since the start of the "Covid-19" pandemic by comparing their glycemic and degenerative profiles in the pre-confinement,per and post-confinement periods. PATIENTS AND METHODS: This is a descriptive and analytical,cross-sectional study,bringing together 720 type 2 diabetic patients followed by teleconsultation at the endocrinology,diabetology and nutrition department,from mid-March to mid-October 2020. RESULTS: The mean age of the patients was 62.5 ± 11.3 years, with a sex ratio (M / F) of 0.71,the average duration of diabetes was 10.6 ± 7, 4 years.The mean pre-lockdown Hba1c level was 8.5±1.9%.Only 137 patients have been able to do the HBa1c test since the start of lockdown,which averaged 8.4 ± 1.8%.Regarding the degenerative complications installed after containment,4.4% of the patients presented an acute coronary syndrome,2.2% a cerebrovascular accident,1.4% developed a stage 2 chronic renal disease,and a foot injury appeared in 5.1% of patients while no patient developed diabetic retinopathy among those who performed ophthalmic evaluation.In our series,the death rate was estimated at 1.8%.Drug therapy was adjusted in the majority of patients with initiation of insulin therapy in 7.2% of patients and intensification of insulin doses in 9.4% of patients. CONCLUSION: At the heart of the pandemic Covid-19 crisis,teleconsultation has taken an essential place in the strategy of access to care, particularly the monitoring of chronic diseases,the results of our study are similar to those of other studies published during this pandemic. Elsevier 2022-04-29 /pmc/articles/PMC9050607/ /pubmed/35505685 http://dx.doi.org/10.1016/j.amsu.2022.103689 Text en © 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Cohort Study
Elmehraoui, O.
Berrabeh, S.
Messaoudi, N.
Derkaoui, N.
Zerrouki, D.
Rouf, S.
Latrech, H.
Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation
title Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation
title_full Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation
title_fullStr Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation
title_full_unstemmed Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation
title_short Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation
title_sort monitoring of type 2 diabetic patients during the ‘covid 19’ pandemic by teleconsultation
topic Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050607/
https://www.ncbi.nlm.nih.gov/pubmed/35505685
http://dx.doi.org/10.1016/j.amsu.2022.103689
work_keys_str_mv AT elmehraouio monitoringoftype2diabeticpatientsduringthecovid19pandemicbyteleconsultation
AT berrabehs monitoringoftype2diabeticpatientsduringthecovid19pandemicbyteleconsultation
AT messaoudin monitoringoftype2diabeticpatientsduringthecovid19pandemicbyteleconsultation
AT derkaouin monitoringoftype2diabeticpatientsduringthecovid19pandemicbyteleconsultation
AT zerroukid monitoringoftype2diabeticpatientsduringthecovid19pandemicbyteleconsultation
AT roufs monitoringoftype2diabeticpatientsduringthecovid19pandemicbyteleconsultation
AT latrechh monitoringoftype2diabeticpatientsduringthecovid19pandemicbyteleconsultation